𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Biological and clinical implications of EGFR mutations in lung cancer

✍ Scribed by Tetsuya Mitsudomi; Takayuki Kosaka; Yasushi Yatabe


Publisher
Springer
Year
2006
Tongue
English
Weight
457 KB
Volume
11
Category
Article
ISSN
1341-9625

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


EGFR and erbB2 mutation status in Japane
✍ Hidefumi Sasaki; Shigeki Shimizu; Katsuhiko Endo; Minoru Takada; Masaaki Kawahar πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 302 KB

## Abstract Much evidence has accumulated that the epidermal growth factor receptor (__EGFR__) and its family members are strongly implicated in the development and progression of lung cancers. Somatic mutations of the __EGFR__ gene were found in about 25–40% of Japanese lung cancer patients. More

Frequent EGFR mutations in brain metasta
✍ Shingo Matsumoto; Kenji Takahashi; Reika Iwakawa; Yoshihiro Matsuno; Yukihiro Na πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 249 KB

## Abstract Lung adenocarcinomas often metastasize to the brain, and the prognosis of patients with brain metastases is still very poor. The __epidermal growth factor receptor__ (__EGFR__) gene is mutated in a considerable fraction of primary lung adenocarcinomas, in particular those with drastic r

Mitochondrial DNA mutations in respirato
✍ Santanu Dasgupta; Ethan Soudry; Nitai Mukhopadhyay; Chunbo Shao; John Yee; Steph πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 252 KB πŸ‘ 1 views

## Abstract Mitochondrial DNA (mtDNA) mutations were reported in different cancers. However, the nature and role of mtDNA mutation in never‐smoker lung cancer patients including patients with epidermal growth factor receptor (__EGFR__) and __KRAS__ gene mutation are unknown. In the present study, w